Behavioral Symptoms: Clinical Trials

48 trials for Behavioral Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 unknown. 48 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 348Unknown 48
Phase 29Unknown 9

Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression
INtegral Cognitive REMediation program, Psychoeducation for depression - Depression, Depressive Disorder
Phase 3UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2962023-09-132024-10-01
Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation
Ketamine Hydrochloride, Normal saline - Suicidal Ideation
Phase 3UnknownUniversity of Ottawa202023-06-012023-02-13
Transcendental Meditation and PTSD
TM, PCT - Ptsd, Depressive Symptoms
Phase 3UnknownDavid Lynch Foundation4502021-10-012021-04-22
The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder
FMT oral Capsules, Placebo Capsules - Depression, Treatment Resistant Depression
Phase 2 / Phase 3UnknownUniversity of Calgary802021-03-042023-11-28
The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity
Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175, placebo - Depressive Disorder, Depression
Phase 3UnknownMedical University of Lodz2002020-12-172021-02-16
Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
Vortioxetine 10 mg, Placebo - Radiation Injuries
Phase 3UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University2082020-10-102021-03-26
The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children
Fluoxetine, Placebo - Nocturnal Enuresis
Phase 3UnknownMansoura University1002020-07-012020-12-19
Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic
Therapist Guided E-Therapy, Self-Help Therapy - Depressive Symptoms, Generalized Anxiety
Phase 3UnknownSultan Qaboos University702020-06-012020-05-08
NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
NRX-101, Lurasidone HCl - Bipolar Depression, Suicidal Ideation
Phase 3UnknownNeuroRx, Inc.722019-12-012024-01-19
A Study of Staccato Loxapine (ADASUVE®) for Inhalation
Inhaled loxapine, Inhaled placebo - Psychomotor Agitation, Schizophrenia
Phase 3UnknownLee's Pharmaceutical Limited1502019-12-012019-11-05
What Amount of Stress is Enough for a Successful Conception?
Midazolam 7.5mg - In Vitro Fertilization, Stress
Phase 3UnknownUniversity Hospital Sestre Milosrdnice402019-09-012019-11-13
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Ketamine Hydrochloride, Placebo - Bipolar Depression, Suicidal Ideation
Phase 3UnknownNeuroRx, Inc.1502019-06-252024-01-19
Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
Ketamine 50 MG/ML Injectable Solution, 0.5 mg/kg IV - Treatment Resistant Depression
Phase 3UnknownNational Institute of Neurology and Neurosurgery, Mexico302018-10-012019-09-10
Intervening to Repair Cognitive and Behavioural Problems in Adults Exposed to Childhood Malnutrition
Exercise plus omega-3 supplement, Placebo - Severe Acute Malnutrition, Cognitive Impairment
Phase 3UnknownThe University of The West Indies1002018-01-152019-08-12
Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder
Allogenic FMT, Autologous FMT - Bipolar Depression
Phase 2 / Phase 3UnknownValerie Taylor352018-01-012022-05-04
Pharmacogenetics in Primary Care Psychotropics
Pharmacogenetic testing - Depression, Obsessive-Compulsive Disorder
Phase 3UnknownUniversity of Arizona1302017-08-152017-07-28
Improving South African Government Workers' Capacities to Deliver HIV Interventions
Accountable Condition, Control Condition - HIV, Partner Violence
Phase 2 / Phase 3UnknownUniversity of California, Los Angeles8402017-06-012021-10-14
RCT of the Effectiveness of the WfWI Intervention in Afghanistan
Women for Women International Intervention - Domestic Violence, Depressive Symptoms
Phase 3UnknownMedical Research Council, South Africa14612016-10-012017-08-02
Emergency Ketamine Treatment of Suicidal Ideation
Intranasal Ketamine, Intranasal Saline Placebo - Depression, Suicidal Ideation
Phase 2 / Phase 3UnknownUniversity of Cincinnati602016-08-012016-08-05
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Escitalopram, placebo - GBM, Depression
Phase 2 / Phase 3UnknownTel-Aviv Sourasky Medical Center1002015-12-012015-12-07

Showing 20 of 48. Sign in to see all of them.

Narrower conditions

Depression (33)  ·  Suicidal Ideation (9)  ·  Anxiety Disorders (6)  ·  Bipolar Disorder (5)  ·  Depressive Disorder, Major (5)  ·  Stress Disorders, Post-Traumatic (4)  ·  Pain (3)  ·  Self-Injurious Behavior (3)  ·  Alcohol Drinking (2)  ·  Cognitive Dysfunction (2)  ·  Depressive Disorder (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Emergencies (2)  ·  Generalized Anxiety Disorder (2)  ·  Intellectual Disability (2)

Broader conditions

Behavior (47)  ·  Mental Disorders (27)  ·  Mood Disorders (12)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Self-Injurious Behavior (9)  ·  Signs and Symptoms (9)  ·  Suicide (9)  ·  Neurologic Manifestations (7)  ·  Nervous System Diseases (6)  ·  Pathologic Processes (6)  ·  Bipolar and Related Disorders (5)  ·  Depressive Disorder (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Stress Disorders, Traumatic (4)

Interventions

Ketamine (7)  ·  Escitalopram (2)  ·  Pharmacogenomic Testing (2)  ·  Sodium Chloride (2)  ·  Transcranial Magnetic Stimulation (2)  ·  (tris(diphenylphosphinomethyl)phenylborate)(p-tolylnitrido)iron(I) (1)  ·  Amlodipine (1)  ·  Analgesia (1)  ·  Buprenorphine (1)  ·  Bupropion (1)  ·  Counseling (1)  ·  Desvenlafaxine Succinate (1)  ·  Dexetimide (1)  ·  Ethanol (1)  ·  Exercise (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  NeuroRx, Inc. (2)  ·  Phytopharm Consulting Brazil (2)  ·  Tel-Aviv Sourasky Medical Center (2)  ·  Abarbanel Mental Health Center (1)  ·  Canadian Breast Cancer Research Alliance (1)  ·  Centre hospitalier de Ville-Evrard, France (1)  ·  David Lynch Foundation (1)  ·  Fr Muller Homoeopathic Medical College (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Gateshead Health NHS Foundation Trust (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium (1)  ·  Indiana University (1)

Countries

United States (9)  ·  Canada (5)  ·  Brazil (4)  ·  Israel (4)  ·  United Kingdom (3)  ·  China (2)  ·  Italy (2)  ·  Croatia (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Jamaica (1)  ·  Malaysia (1)

Top investigators

Carla Vanin, MD MSc PhD (2)  ·  Martin Brecher, MD (2)  ·  Valerie Taylor, MD, PhD (2)  ·  Ahmed Abdelhalem (1)  ·  Alan Thomas, Dr (1)  ·  Anne E. van Giezen, Dr. (1)  ·  Anne E.M. Speckens, Prof. dr. (1)  ·  Arnold A.P. van Emmerik, Dr. (1)  ·  Barry J.A. Laird, MD (1)  ·  Cheryl McCullumsmith, MD PhD (1)  ·  Chong Guan Ng, MBBS, MPM (1)  ·  Claudio N Soares, MD, PhD (1)  ·  Claus Normann, MD (1)  ·  Dieter Schoepf, MD (1)  ·  Fei Hsiao, PhD (1)

Results publications

PMID 10686270, PMID 12756930, PMID 12813115, PMID 12836501, PMID 15644873, PMID 15677610, PMID 15748841, PMID 16040444, PMID 16390886, PMID 16873325, PMID 16894061, PMID 17074942, PMID 17210143, PMID 17541113, PMID 17717958, PMID 18073775, PMID 18188442, PMID 18704022, PMID 18801471, PMID 18976268, PMID 19058788, PMID 19777535, PMID 20006865, PMID 20194822, PMID 20616670, PMID 20628129, PMID 20661246, PMID 20673547, PMID 20679587, PMID 20700385, PMID 20937930, PMID 21145043, PMID 21232924, PMID 21494337, PMID 21672551, PMID 22212598, PMID 22217452, PMID 22297150, PMID 22500865, PMID 22753637, PMID 22777127, PMID 22840761, PMID 22951236, PMID 22954259, PMID 23023681, PMID 23042884, PMID 23053829, PMID 23273725, PMID 23428794, PMID 23546169

NIH funding

R01MH111391 (1)